Comparative analysis of anti-dsDNA immunoassays shows similar performance in systemic lupus erythematosus, suggesting optimal selection aids clinical decisions.
We confirmed that the clinical performances of the three dsDNA immunoassays are comparable. Our findings suggest that selecting an optimal anti-dsDNA immunoassay will be useful for clinical decision-making in SLE.
No takes yet. Share an insight, caveat, or question.
Uto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: